← Open Payments lookup

AMBER PHEBUS: Open Payments

NPI 1639809528 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$500 in 23 payments from 11 companies in 2025. Trend: 2023 $49 · 2024 $687 · 2025 $500

Food & beverage: $500
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc5$159
Axsome Therapeutics, Inc.2$60
Alkermes, Inc.3$58
Noven Therapeutics, LLC3$55
ABBVIE INC.3$48
Takeda Pharmaceuticals U.S.A., Inc.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Corium, LLC1$20
Vanda Pharmaceuticals Inc.1$15
Otsuka America Pharmaceutical, Inc.1$15

Products named: SPRAVATO, Auvelity, Xelstrym, VRAYLAR, ARISTADA, TRINTELLIX, CAPLYTA, Azstarys.

Industry payments across IN — which companies pay providers there.